Turnstone Biologics Corp (TSBX) Halted, News Pending Jun 27, 2025 07:25AM
Turnstone Biologics Corp. (TSBX) Tops Q1 EPS by 17c May 9, 2025 06:34AM
Piper Sandler Downgrades Turnstone Biologics (TSBX) to Neutral Feb 5, 2025 04:13AM
Turnstone Biologics Corp (TSBX) to Explore Strategic Alternatives Feb 4, 2025 09:00AM
BofA Securities Downgrades Turnstone Biologics (TSBX) to Underperform Nov 15, 2024 06:13AM


Nov 5, 2024 09:01AM Turnstone Biologics Corp (TSBX) Presents Preclinical Data Highlighting Potential for Selected Tumor-Infiltrating Lymphocyte Therapy
Oct 14, 2024 06:11AM BofA Securities Downgrades Turnstone Biologics (TSBX) to Neutral
Oct 11, 2024 06:00AM Turnstone Biologics Corp (TSBX) Announces Strategic Restructuring
Aug 19, 2024 08:52AM Turnstone Biologics (TSBX) PT Lowered to $3.75 at Piper Sandler
Aug 14, 2024 04:01PM Turnstone Biologics Corp (TSBX) Reports Positive Initial Data from Phase 1 Trial of TIDAL-01 in Metastatic Colorectal Cancer